These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9593123)

  • 41. Genetics of extended-spectrum beta-lactamases.
    Jacoby GA
    Eur J Clin Microbiol Infect Dis; 1994; 13 Suppl 1():S2-11. PubMed ID: 7821301
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of beta-lactamases responsible for resistance to extended-spectrum cephalosporins in Escherichia coli and Salmonella enterica strains from food-producing animals in the United Kingdom.
    Liebana E; Gibbs M; Clouting C; Barker L; Clifton-Hadley FA; Pleydell E; Abdalhamid B; Hanson ND; Martin L; Poppe C; Davies RH
    Microb Drug Resist; 2004; 10(1):1-9. PubMed ID: 15140388
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A natural polymorphism in beta-lactamase is a global suppressor.
    Huang W; Palzkill T
    Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8801-6. PubMed ID: 9238058
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transfer of resistance to oxy-imino-cephalosporins and of extended-spectrum beta-lactamase productions in Klebsiella pneumoniae strains from infected neonates.
    Blahová J; Hupková M; Králiková K; Krcméry V; Lísková A; Kubonová K
    Zentralbl Bakteriol; 1998 Jul; 288(1):75-86. PubMed ID: 9728407
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cloning and sequencing of the gene encoding Toho-2, a class A beta-lactamase preferentially inhibited by tazobactam.
    Ma L; Ishii Y; Ishiguro M; Matsuzawa H; Yamaguchi K
    Antimicrob Agents Chemother; 1998 May; 42(5):1181-6. PubMed ID: 9593147
    [TBL] [Abstract][Full Text] [Related]  

  • 46. E240V substitution increases catalytic efficiency toward ceftazidime in a new natural TEM-type extended-spectrum beta-lactamase, TEM-149, from Enterobacter aerogenes and Serratia marcescens clinical isolates.
    Perilli M; Celenza G; De Santis F; Pellegrini C; Forcella C; Rossolini GM; Stefani S; Amicosante G
    Antimicrob Agents Chemother; 2008 Mar; 52(3):915-9. PubMed ID: 18160520
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extended-spectrum beta-lactamases in ceftazidime-resistant Escherichia coli and Klebsiella pneumoniae isolates in Turkish hospitals.
    Hoşoğlu S; Gündes S; Kolayli F; Karadenizli A; Demirdağ K; Günaydin M; Altindis M; Caylan R; Ucmak H
    Indian J Med Microbiol; 2007 Oct; 25(4):346-50. PubMed ID: 18087082
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of beta-lactamases among ampicillin-resistant Escherichia coli and Salmonella isolated from food animals in Denmark.
    Olesen I; Hasman H; Aarestrup FM
    Microb Drug Resist; 2004; 10(4):334-40. PubMed ID: 15650379
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systematic mutagenesis of the active site omega loop of TEM-1 beta-lactamase.
    Petrosino JF; Palzkill T
    J Bacteriol; 1996 Apr; 178(7):1821-8. PubMed ID: 8606154
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extended-spectrum beta-lactamases in Escherichia coli and Klebsiella spp. in European septicaemia isolates.
    Pörnull KJ; Göransson E; Rytting AS; Dornbusch K
    J Antimicrob Chemother; 1993 Oct; 32(4):559-70. PubMed ID: 8288497
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Meropenem against bacteria carriers of wide spectrum TEM beta-lactamases: evolutive aspects].
    Baquero F; Morosini MI; Negri MC; Cantón R; Blázquez J
    Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():27-31. PubMed ID: 9410066
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contribution of PBP3 Substitutions and TEM-1, TEM-15, and ROB-1 Beta-Lactamases to Cefotaxime Resistance in Haemophilus influenzae and Haemophilus parainfluenzae.
    Søndergaard A; Nørskov-Lauritsen N
    Microb Drug Resist; 2016 Jun; 22(4):247-52. PubMed ID: 26683319
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Construction and characterization of mutants of the TEM-1 beta-lactamase containing amino acid substitutions associated with both extended-spectrum resistance and resistance to beta-lactamase inhibitors.
    Stapleton PD; Shannon KP; French GL
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1881-7. PubMed ID: 10428907
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TEM-184, a Novel TEM-Derived Extended-Spectrum β-Lactamase with Enhanced Activity against Aztreonam.
    Piccirilli A; Perilli M; Amicosante G; Conte V; Tascini C; Rossolini GM; Giani T
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941651
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitory activity of avibactam against selected β-lactamases expressed in an isogenic Escherichia coli strain.
    Giani T; Cannatelli A; Di Pilato V; Testa R; Nichols WW; Rossolini GM
    Diagn Microbiol Infect Dis; 2016 Sep; 86(1):83-5. PubMed ID: 27394638
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia.
    Rasheed JK; Jay C; Metchock B; Berkowitz F; Weigel L; Crellin J; Steward C; Hill B; Medeiros AA; Tenover FC
    Antimicrob Agents Chemother; 1997 Mar; 41(3):647-53. PubMed ID: 9056008
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A secondary drug resistance mutation of TEM-1 beta-lactamase that suppresses misfolding and aggregation.
    Sideraki V; Huang W; Palzkill T; Gilbert HF
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):283-8. PubMed ID: 11114163
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
    Tofteland S; Haldorsen B; Dahl KH; Simonsen GS; Steinbakk M; Walsh TR; Sundsfjord A;
    J Clin Microbiol; 2007 Jan; 45(1):199-205. PubMed ID: 17079502
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Detection of CTX-M-15 type extended spectrum beta-lactamase in an Escherichia coli strain isolated from the urine sample of a hospitalized patient].
    Aktaş Z; Gönüllü N; Schneider I; Bal C; Bauernfeind A
    Mikrobiyol Bul; 2005 Oct; 39(4):421-9. PubMed ID: 16544543
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins.
    Berrazeg M; Jeannot K; Ntsogo Enguéné VY; Broutin I; Loeffert S; Fournier D; Plésiat P
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6248-55. PubMed ID: 26248364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.